"It was impressive to see that every dose of retatrutide resulted in clinically meaningful weight reduction for nearly all participants and people with severe obesity on the highest dose lost on average 30% of their body weight during two years." Importantly, treatment with retatrutide not only resulted in robust weight reduction, but also in clear improvements in assessed cardiometabolic health measures
This involved modifying the structure of GLP-1 to enhance its stability and prolong its activity in the body
In March, another paper in JAMA Ophthalmology looked at optic nerve problems (NAION) among patients with Type 2 diabetes who took GLP-1 drugs
2025;48(3):e25-e27
A Big Win For The UK Given the program has only just been formed, it remains to be seen what type of results its going to deliver long term
Other conditions associated with low glutathione include asthma, cancer, lyme disease, rheumatoid arthritis, neurodegenerative diseases, acquired immune deficiency syndrome (AIDS), aging, cystic fibrosis, liver and heart disease, ischemia, stroke, seizure, sickle cell anemia and metabolic diseases such as diabetes and obesity
.png)
